MPP participated in the World Cancer Congress 2022 that took took place 18-20 October 2022 at the CICG – The International Conference Center Geneva with over 1,700 registered participants from 120 countries.
On Tuesday 18 October 2022, our MPP Head of Strategy, Policy and Market Access, Esteban Burrone participated in a discussion on “Increasing Access to Quality Assured and Affordable Essential Medicines for Cancer Care in Low- and Middle-Income Countries – How Can We Make This Happen?”
Panelists:
Esteban Burrone • Medicines Patent Pool
Dr. Mary Flaviane Nyangasi • National Cancer Control Program, Kenya
Dr. Yehoda Martei • Abramson Cancer Center, University of Pennsylvania
Christpoher Lim • PAHO
Pat Garcia-Gonzalez • The Max Foundation
On Wednesday 19 October 2022, those in attendance had a chance to meet Giulia Segafredo, our NCDs Access Manager, as she discussed “What is Voluntary Licensing and Why Does it Matter to Access Cancer Medicines?”
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.